Abbott Laboratories ABT will release earnings results for its third quarter, before the opening bell on Wednesday, Oct. 16.Analysts expect the North Chicago, Illinois-based company to report quarterly earnings at $1.2 per share, up from $1.14 per share in the year-ago period. Abbott projects to report revenue of $10.55 billion for the quarter, according to data from Benzinga Pro.On Sept. 19, the company's board of directors declared a quarterly common dividend of 55 cents per share.Abbott shares fell 0.6% t ...

Big banks continue to highlight this week’s earnings lineup but several stocks are standing out from various industries that are in the top 40% of over 250 Zacks industries. Sporting a Zacks Rank #2 (Buy) here are three of these top-rated stocks that investors will want to consider as their Q3 results approach on Wednesday, October 16. Abbott Laboratories Industry: Medical Products Starting with a medical standout, Abbott Laboratories (ABT)  stock is attractive as a provider of pharmaceutical products, diag ...

Investors are always looking for stocks that are poised to beat at earnings season and Abbott Laboratories (ABT) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Abbott is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good ind ...

The stock of healthcare behemoth Abbott Laboratories (NYSE: ABT ) has experienced an uninspiring 2024 so far; in a year where the prime equity bellwether has generated solid returns of 23%, and even the healthcare cohort of the S&P 500Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensati ...

CHINA - 2024/09/17: In this photo illustration, Abbott Laboratories logo is displayed on a ... [+] smartphone with a S&P index website background. (Photo Illustration by Alvin Chan/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesAbbott (NYSE: ABT) will report its Q3 2024 results on Wednesday, Oct 16. We expect the company to post revenue of $10.6 billion and earnings of $1.20 on a per share and adjusted basis, aligning with the street expectations. We expect the company to p ...

In its upcoming report, Abbott (ABT) is predicted by Wall Street analysts to post quarterly earnings of $1.20 per share, reflecting an increase of 5.3% compared to the same period last year. Revenues are forecasted to be $10.56 billion, representing a year-over-year increase of 4.1%.The consensus EPS estimate for the quarter has undergone a downward revision of 0.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial est ...

Enrollment completed ahead of schedule in the global IDE for Abbott's Volt™ PFA SystemGlobal FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™Advisor™ HD Grid X Mapping Catheter, Sensor Enabled™, receives U.S. Food and Drug Administration clearance, begins commercial launchABBOTT PARK, Ill., Oct. 10, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solut ...

The market expects Abbott (ABT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Considering buying ABT stock? Here's what analysts think: B Read More: ...

Abbott (ABT) closed the most recent trading day at $113.64, moving +0.07% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.01%. Meanwhile, the Dow gained 0.09%, and the Nasdaq, a tech-heavy index, added 0.08%. The maker of infant formula, medical devices and drugs's shares have seen a decrease of 0.96% over the last month, surpassing the Medical sector's loss of 3.6% and falling behind the S&P 500's gain of 1.21%. Investors will be eagerly watching for th ...